GBE1 and diabetes mellitus: In a recent review, Li and Hu argued that the abnormally long chain length distribution in diabetic liver was controlled by the imbalance of enzymatic activities between glycogen synthase (GS) and GBE, which could also serve as a therapeutic target for diabetes (Li and Hu, 2019).